Chadani et al. 2021 (PRJNA764085)

General Details

Title Nascent polypeptide within the exit tunnel stabilizes the ribosome to counteract risky translation
Organism
Number of Samples 4
Release Date 2021/09/17 00:00
Sequencing Types
Protocol Details

Study Links

Repository Details

SRA SRP337604
ENA SRP337604
GEO GSE184331
BioProject PRJNA764085

Publication

Title
Authors Chadani Y,Sugata N,Niwa T,Ito Y,Iwasaki S,Taguchi H
Journal The EMBO journal
Publication Date 2021 Dec 1
Abstract Continuous translation elongation, irrespective of amino acid sequences, is a prerequisite for living organisms to produce their proteomes. However, nascent polypeptide products bear an inherent risk of elongation abortion. For example, negatively charged sequences with occasional intermittent prolines, termed intrinsic ribosome destabilization (IRD) sequences, weaken the translating ribosomal complex, causing certain nascent chain sequences to prematurely terminate translation. Here, we show that most potential IRD sequences in the middle of open reading frames remain cryptic and do not interrupt translation, due to two features of the nascent polypeptide. Firstly, the nascent polypeptide itself spans the exit tunnel, and secondly, its bulky amino acid residues occupy the tunnel entrance region, thereby serving as a bridge and protecting the large and small ribosomal subunits from dissociation. Thus, nascent polypeptide products have an inbuilt ability to ensure elongation continuity. © 2021 The Authors.
PMC PMC8634131
PMID 34672004
DOI
Run Accession Study Accession Scientific Name Cell Line Library Type Treatment GWIPS-viz Trips-Viz Reads BAM BigWig (F) BigWig (R)
SRR15929424 PRJNA764085 Escherichia coli Ribo-Seq
SRR15929425 PRJNA764085 Escherichia coli Ribo-Seq
SRR15929426 PRJNA764085 Escherichia coli Ribo-Seq
SRR15929427 PRJNA764085 Escherichia coli Ribo-Seq
Run Accession Study Accession Scientific Name Cell Line Library Type Treatment GWIPS-viz Trips-Viz Reads BAM BigWig (F) BigWig (R)

ⓘ For more Information on the columns shown here see: About